Helen S. Mayberg
Helen S. Mayberg (born 1956 in
California), is an American
neurologist. Mayberg is known in particular for her work delineating abnormal
brain function in patients with
major depression using
functional neuroimaging. This work led to the first pilot study of
deep brain stimulation (DBS), a reversible method of selective modulation of a specific brain circuit, for patients with
treatment-resistant depression. As of August 2019, she has published 211 original peer-reviewed articles, 31 books and book chapters, and acted as principal investigator on 24 research grants. Mayberg is coinventor with Andres Lozano of “Method for Treating Depression Mood Disorders and Anxiety Disorders using
Neuromodulation,” US patent 2005/0033379A1.
St. Jude Medical Neuromodulation licensed her
intellectual property to develop [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4423545/ Subcallosal Cingulate Deep Brain Stimulation for Treatment-Resistant Unipolar and Bipolar Depression] (SCC DBS) for the treatment of
severe depression. As of 2018, Mayberg holds positions as Professor of Neurology and Neurosurgery and Professor, Psychiatry and Neuroscience, both at
Mount Sinai Medical School, and Professor of Psychiatry, Emory University;
Emory University Hospital. Since 2018, she has served as Director, Nash Family Center for Advanced Circuit Therapeutics at the
Icahn School of Medicine at Mount Sinai.
Provided by Wikipedia